Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel C Chambers

Showing results (111-120 of 127) with videos related to

Pageof 13
Sort By:
The Journal of Experimental Medicine|January 10, 2020
Dynamics of human monocytes and airway macrophages during healthy aging and after transplantAdam J Byrne, Joseph E Powell, Brendan J O'Sullivan, et al.
American Journal of Respiratory and Critical Care Medicine|June 30, 2022
A Phase IIb Randomized Clinical Study of an Anti-α<sub>v</sub>β<sub>6</sub> Monoclonal Antibody in Idiopathic Pulmonary FibrosisGanesh Raghu, Majd Mouded, Daniel C Chambers, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|November 5, 2018
Bronchiolitis obliterans syndrome-free survival after lung transplantation: An International Society for Heart and Lung Transplantation Thoracic Transplant Registry analysisHrishikesh S Kulkarni, Wida S Cherikh, Daniel C Chambers, et al.
BMJ Open Respiratory Research|December 3, 2021
TELO-SCOPE study: a randomised, double-blind, placebo-controlled, phase 2 trial of danazol for short telomere related pulmonary fibrosisJohn A Mackintosh, Maria Pietsch, Viviana Lutzky, et al.
Science Immunology|October 24, 2020
Itaconate controls the severity of pulmonary fibrosisPatricia P Ogger, Gesa J Albers, Richard J Hewitt, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|October 18, 2021
The evolution of the ISHLT transplant registry. Preparing for the futureJosef Stehlik, Jason D Christie, Daniel R Goldstein, et al.
Respiratory Research|December 5, 2025
A randomised clinical trial of a digital self-management package for people with interstitial lung disease: the REBUILD-SM protocolCarly Barton, Mariana Hoffman, Narelle S Cox, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|February 14, 2024
Management of infectious disease syndromes in thoracic organ transplants and mechanical circulatory device recipients: a Delphi panelMe-Linh Luong, Yoshiko Nakamachi, Fernanda P Silveira, et al.
Chest|January 9, 2023
Sex- and Race-Based Differences in the Treatment of Interstitial Lung Diseases in North America and AustralasiaDeborah Assayag, Ayodeji Adegunsoye, Robert Sheehy, et al.
Trials|November 23, 2024
Trial protocol for SiroSkin: a randomised double-blind placebo-controlled trial of topical sirolimus in chemoprevention of facial squamous cell carcinomas in solid organ transplant recipientsLea Dousset, Daniel C Chambers, Angela Webster, et al.
Pageof 13

Showing results (111-120 of 127) with videos related to

Sort By:
Pageof 13
The Journal of Experimental Medicine|January 10, 2020
Dynamics of human monocytes and airway macrophages during healthy aging and after transplantAdam J Byrne, Joseph E Powell, Brendan J O'Sullivan, et al.
American Journal of Respiratory and Critical Care Medicine|June 30, 2022
A Phase IIb Randomized Clinical Study of an Anti-α<sub>v</sub>β<sub>6</sub> Monoclonal Antibody in Idiopathic Pulmonary FibrosisGanesh Raghu, Majd Mouded, Daniel C Chambers, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|November 5, 2018
Bronchiolitis obliterans syndrome-free survival after lung transplantation: An International Society for Heart and Lung Transplantation Thoracic Transplant Registry analysisHrishikesh S Kulkarni, Wida S Cherikh, Daniel C Chambers, et al.
BMJ Open Respiratory Research|December 3, 2021
TELO-SCOPE study: a randomised, double-blind, placebo-controlled, phase 2 trial of danazol for short telomere related pulmonary fibrosisJohn A Mackintosh, Maria Pietsch, Viviana Lutzky, et al.
Science Immunology|October 24, 2020
Itaconate controls the severity of pulmonary fibrosisPatricia P Ogger, Gesa J Albers, Richard J Hewitt, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|October 18, 2021
The evolution of the ISHLT transplant registry. Preparing for the futureJosef Stehlik, Jason D Christie, Daniel R Goldstein, et al.
Respiratory Research|December 5, 2025
A randomised clinical trial of a digital self-management package for people with interstitial lung disease: the REBUILD-SM protocolCarly Barton, Mariana Hoffman, Narelle S Cox, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|February 14, 2024
Management of infectious disease syndromes in thoracic organ transplants and mechanical circulatory device recipients: a Delphi panelMe-Linh Luong, Yoshiko Nakamachi, Fernanda P Silveira, et al.
Chest|January 9, 2023
Sex- and Race-Based Differences in the Treatment of Interstitial Lung Diseases in North America and AustralasiaDeborah Assayag, Ayodeji Adegunsoye, Robert Sheehy, et al.
Trials|November 23, 2024
Trial protocol for SiroSkin: a randomised double-blind placebo-controlled trial of topical sirolimus in chemoprevention of facial squamous cell carcinomas in solid organ transplant recipientsLea Dousset, Daniel C Chambers, Angela Webster, et al.
Pageof 13